Dr. Kunle Odunsi, the Director of the University of Chicago Medicine Comprehensive Cancer Center, is a distinguished figure in the realm of ovarian cancer research. His leadership at the cancer center underscores his commitment to advancing innovative and personalized approaches to cancer care. Dr. Odunsi also holds the role of Associate Director on the CRI Scientific Advisory Council, contributing his expertise to guide the strategic direction of cancer immunotherapy research. With a specific focus on ovarian cancer, Dr. Odunsi's contributions have been pivotal in deepening our understanding of this complex disease and exploring novel treatment modalities. His dual role as a cancer center director and scientific advisor positions him as a key influencer in shaping the landscape of ovarian cancer research and underscores his dedication to improving outcomes for patients affected by this challenging malignancy.
Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. [ Ссылка ]
Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.
